Summary
In a significant market movement during July 2021, NanoSyrinx was the subject of a vc funding. The transaction achieved a gross valuation of £6,200,000. Leading the round was M Ventures, BioCity, IQ Capital, Octopus Ventures, UK Innovation & Science Seed Fund, Jonathan Milner..
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
M Ventures
Lead Investor / Acquirer
BioCity
Lead Investor / Acquirer
IQ Capital
Lead Investor / Acquirer
Octopus Ventures
Lead Investor / Acquirer
UK Innovation
Lead Investor / Acquirer
Science Seed Fund
Lead Investor / Acquirer
Jonathan Milner.
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in